Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis

MLA

Xue Song, et al. “Cost of Peripheral Neuropathy in Patients Receiving Treatment for Multiple Myeloma: A US Administrative Claims Analysis.” Therapeutic Advances in Hematology, vol. 10, Mar. 2019. EBSCOhost, https://doi.org/10.1177/2040620719839025.

APA

Xue Song, Kathleen L. Wilson, Jerry Kagan, & Sumeet Panjabi. (2019). Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis. Therapeutic Advances in Hematology, 10. https://doi.org/10.1177/2040620719839025

Chicago

Xue Song, Kathleen L. Wilson, Jerry Kagan, and Sumeet Panjabi. 2019. “Cost of Peripheral Neuropathy in Patients Receiving Treatment for Multiple Myeloma: A US Administrative Claims Analysis.” Therapeutic Advances in Hematology 10 (March). doi:10.1177/2040620719839025.